Stockscreener 앱 받기
47.56
3.39%
-1.67
시간 외 거래:
47.59
0.03
+0.06%
전일 마감가:
$49.23
열려 있는:
$48.25
하루 거래량:
1.42M
Relative Volume:
1.07
시가총액:
$1.52B
수익:
$117.67M
순이익/손실:
$-1.88B
주가수익비율:
-0.7856
EPS:
-60.5369
순현금흐름:
$-621.36M
1주 성능:
+3.00%
1개월 성능:
+26.83%
6개월 성능:
+165.40%
1년 성능:
+216.01%
1일 변동 폭
$45.37
$48.94
1주일 범위
$45.37
$52.56
52주 변동 폭
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
명칭
Grail Inc
전화
(833) 694-2553
주소
1525 O'BRIEN DRIVE, MENLO PARK
GRAL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
47.56 | 1.52B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Canaccord Genuity | Buy |
| 2024-11-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-10-17 | 개시 | Guggenheim | Neutral |
Grail Inc 주식(GRAL)의 최신 뉴스
Grail plans to submit updated Galleri blood test for FDA approval next year - Fierce Biotech
Grail stock gains on new data for Galleri cancer test (GRAL) - Seeking Alpha
GRAIL reports positive results from cancer detection test study By Investing.com - Investing.com Nigeria
GRAIL reports positive results from cancer detection test study - Investing.com Australia
GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study - MarketScreener
Grail reports results from PATHFINDER 2 study - TipRanks
Revolutionary Cancer Screening Test Achieves Major Clinical Success: GRAIL's Galleri Outperforms Previous Study - Stock Titan
GRAIL: Too Much A Leap Of Faith (NASDAQ:GRAL) - Seeking Alpha
California State Teachers Retirement System Takes $464,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
67,288 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
NINGI short Grail, says ‘approval and commercialization all but impossible’ - TipRanks
GRAIL stock tumbles on short-seller report By Investing.com - Investing.com Nigeria
GRAIL stock tumbles on short-seller report - Investing.com
Ningi Research Says Short Grail - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - inkl
GRALGRAIL Reports First Quarter 2025 Financial Results - mx.advfn.com
Wellington Management Group LLP Takes Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Two Sigma Advisers LP Makes New $345,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
For FMCG Inc., the holy grail of volume growth is in sight | Company Business News - Mint
Nuveen Asset Management LLC Takes $837,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Transcript : GRAIL, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11 - marketscreener.com
BNP Paribas Financial Markets Invests $50,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Ameriprise Financial Inc. Takes $681,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL, Inc. (GRAL) Stock Analysis: Evaluating the 19.10% Revenue Growth Against Market Challenges - DirectorsTalk Interviews
96,630 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Two Sigma Investments LP - Defense World
GRAIL announces inducement grants - Medical Buyer
Grail Inc. stockholders elect director, ratify auditor By Investing.com - Investing.com Nigeria
Grail Inc. stockholders elect director, ratify auditor - Investing.com
GRAIL Inc Holds Annual Stockholders Meeting - TipRanks
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail (GRAL) and Its Competitors Head-To-Head Analysis - Defense World
Rêve Health to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test - Fitt Insider
Millennium Management LLC Takes $5.28 Million Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
(GRAL) Technical Data - news.stocktradersdaily.com
Man Group plc Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
56,062 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Deutsche Bank AG - Defense World
145,949 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Northern Trust Corp - Defense World
Janus Henderson Group PLC Invests $223,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
595,962 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Bank of America Corp DE - Defense World
Early Cancer Detection Pioneer GRAIL Reveals Latest Advances at Major Healthcare Conference - Stock Titan
GRAIL to Present at Jefferies Global Healthcare Conference 2025 - PR Newswire
Liquid Biopsy Market Is Booming So Rapidly | GRAIL, Freenome, Natera - openPR.com
How to Take Advantage of moves in (GRAL) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL falls 16% after Q1 topline miss - MSN
GRAIL First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biotech startup Grail (GRAL) gets grilled on its cash burn - Investorsobserver
Gravity study shows why the moon's two sides look so different - marketscreener.com
Health Care Sector Slips While Incannex Rockets Ahead - Finimize
Sector Update: Health Care - marketscreener.com
GRAIL and athenahealth partner to simplify ordering of cancer detection test - MSN
Grail Inc (GRAL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.52%
0.53%
자본화:
|
볼륨(24시간):